Skip to main content
Michael Waters PhD
Michael D. Waters PhD (Biochemistry Alum.1969)

If you would like to read Public Comments or to submit ones relative to the 28 November 2021 Antimicrobial Drugs Advisory Committee: Notice of Meeting; Establishment of a Public Docket: Request for Comments (/document/FDA-2021-N-0758-0012), please do so. I (Michael Waters) and my coauthors submitted our preprint on 4 November 2021 and a summary with minor corrections (Michael Dee Waters) on 9 Nov 2021.

Here is the URL for the latter submission:

Docket No. FDA-2021-N-0758


FDA to Hold Advisory Committee Meeting to Discuss Merck and Ridgeback’s EUA Application for COVID-19 Oral Treatment

If you go to regulations.gov and enter the Docket Number FDA-2021-N-0758 and look under the tab Comments, you will see the Public Comments that have been posted so far. #3 is from Ron Swanstrom and #5 is from me. Biochemistry is important in today’s world. All the best to the Department!

Ron Swanstrom PhD
Ronald Swanstrom PhD, Charles P. Postelle, Jr. Distinguished Professor of Biochemistry

Ron Swanstrom PhD submitted his comments and “he should be commended!”

— Michael Dee Waters, PhD, UNC, Biochemistry, 1969. (11/12/2021)


Update on Dec. 23, 2021

The Pills to Fight COVID-19

The FDA has approved antiviral pills you take once you’ve been infected to fight COVID-19. Learn more about the pills and how UNC researchers helped with testing the safety and efficacy of molnupiravir, developed by Ridgeback Biotherapeutics and Merck.